Sodium-Glucose Cotransporter-2 Inhibitors versus Glucagon-Like Peptide 1 Receptor Agonists Effects on Kidney and Clinical Outcomes in Veterans with Type 2 Diabetes
Kidney360
.
2024 Nov 1;5(11):1633-1643.
doi: 10.34067/KID.0000000597.
Epub 2024 Oct 3.
Authors
Candis M Morello
1
2
,
Linda Awdishu
1
,
Stepfanie Lam
3
,
Amy Heman
4
,
Mark Bounthavong
1
5
Affiliations
1
San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla, California.
2
Veterans Affairs San Diego Healthcare System, San Diego, California.
3
Stanford Health Care, Palo Alto, California.
4
Sharp Grossmont Hospital, San Diego, California.
5
Health Economics Resource Center, US Department of Veterans Affairs, Menlo Park, California.
PMID:
39361784
DOI:
10.34067/KID.0000000597
No abstract available